公开(公告)号：US4394186A

公开(公告)日：1983-07-19

申请号：US213175

申请日：1980-12-04

Applicant: Takashi Furukawa ,  Kazuo Koyama

Inventor： Takashi Furukawa ,  Kazuo Koyama

IPC: C22C38/00 ,  C21D1/19 ,  C21D8/04 ,  C21D9/46 ,  C21D8/02

CPC classification number: C21D8/0473 ,  C21D1/19 ,  C21D8/0426

Abstract: A high-strength cold-rolled steel sheet with dual-phase structure, recently developed by the Japanese steel producers have a low yield ratio of approximately 0.6 or lower, is free of the yield-point elongation and is of excellent press-formability. One of the production methods of this steel is a continuous annealing at a temperature range of two-phase structure of ferrite (.alpha.)+austenite (.gamma.). In order to improve the formability, the artificial-aging hardenability after forming, yield ratio and ductility over those of the known dual-phase steel, the present invention provides a method for producing a dual-phase steel, which comprise a step of cooling from the annealing temperature to a temperature not higher than 200.degree. C. at an average cooling rate (R.sub.1) in the range of 1.degree. C./second.gtoreq.R.sub.1 .ltoreq.30.degree. C./second over the primary cooling stage from the annealing temperature down to an intermediate temperature (T) in the range of 420.degree. C..ltoreq.T.ltoreq.700.degree. C., and at an average cooling rate (R.sub.2) in the range of 100.degree. C./second.ltoreq.R.sub.2 .ltoreq.300.degree. C./second over the secondary cooling stage from the intermediate temperature (T) down to the temperature not higher than 200.degree. C.

Abstract translation: 近来由日本钢铁生产商开发的具有双相结构的高强度冷轧钢板的屈服比低约0.6或更低，没有屈服点伸长率并且具有优异的压制成形性。 该钢的制造方法之一是在铁素体（α）+奥氏体（γ）的两相结构的温度范围内进行连续退火。 为了提高成型性，成形后的人造时效淬透性，屈服比和延展性优于已知的双相钢，本发明提供了一种双相钢的制造方法，其包括从 退火温度在不高于200℃的温度下，平均冷却速度（R1）在1℃/秒/秒= 1/30℃/秒的范围内，在一次冷却阶段 退火温度降至中等温度（T）在420℃范围内，平均冷却速率（R2）在100℃/秒的范围内 在二级冷却阶段，从中间温度（T）下降到不高于200℃的温度下，

公开(公告)号：US4376661A

公开(公告)日：1983-03-15

申请号：US048587

申请日：1979-06-13

Applicant: Hiroshi Takechi ,  Munetsugu Matsuo ,  Kazuo Koyama

Inventor： Hiroshi Takechi ,  Munetsugu Matsuo ,  Kazuo Koyama

IPC: B21B3/00 ,  C21D8/02 ,  C21D9/46 ,  C22C38/00 ,  C22C38/04 ,  C21D8/04 ,  C21D9/48

CPC classification number: C22C38/04 ,  C21D8/0273 ,  C21D2211/001 ,  C21D2211/008

Abstract: A method of producing a dual phase structure cold rolled steel sheet having tensile strength 35 to 50 kg/mm.sup.2, yield ratio less than 60% and high elongation which comprises hot rolling and cold rolling by conventional process a steel containing 0.01 to 0.05% C, less than 0.2% Si, 1.7 to 2.5% Mn, 0.01 to 0.10 Al with the balance being Fe and unavoidable impurities, holding the produced steel sheet for 20 seconds to 20 minutes at a temperature 720.degree. to 850.degree. C., and cooling the steel sheet at a cooling speed between 3.degree. and 50.degree. C. per second and also above a value (.degree.C. per second) shown by following formulae:12.times.[Mn(%)].sup.2 -62.times.[Mn(%)]+81.

Abstract translation: 一种制造拉伸强度为35〜50kg / mm2，屈服比小于60％，高伸长率的双相结构冷轧钢板的方法，其包括通过常规方法的热轧和冷轧含有0.01〜0.05％C的钢， 小于0.2％的Si，1.7〜2.5％的Mn，0.01〜0.10的Al，余量为Fe和不可避免的杂质，在720〜850℃的温度下将生成的钢板保持20秒〜20分钟， 钢板以每秒3〜50℃的冷却速度，也高于以下公式所示的值（℃/秒）：12x [Mn（％）] 2-62x [Mn（％）] + 81。

公开(公告)号：US4252171A

公开(公告)日：1981-02-24

申请号：US969136

申请日：1978-12-13

Applicant: Isamu Imai ,  Kazuo Koyama ,  Mitsuaki Maeda

Inventor： Isamu Imai ,  Kazuo Koyama ,  Mitsuaki Maeda

IPC: B60C1/00 ,  B60C11/00 ,  B60C19/00 ,  B60C19/08 ,  C08L7/00 ,  C08L47/00 ,  C08L93/04

CPC classification number: B60C1/0016 ,  B60C19/08 ,  Y10T152/1081

Abstract: A tire having excellent withstand-voltage property, wear resistance and resistance against heat build-up is disclosed. The tire has a tread, at least the contact area of the tread with road surface being made of a rubber composition containing a specifically limited softening agent and a specifically limited carbon black.

Abstract translation: 公开了具有优异的耐电压性，耐磨性和耐发热性的轮胎。 轮胎具有胎面，至少胎面与路面的接触面积由含有特别限定的软化剂和特别限定的炭黑的橡胶组合物制成。

公开(公告)号：US08121566B2

公开(公告)日：2012-02-21

申请号：US12310614

申请日：2007-08-30

Applicant: Masanori Ishida ,  Kazuo Koyama ,  Kazuyoshi Inako ,  Naoki Nakajima

Inventor： Masanori Ishida ,  Kazuo Koyama ,  Kazuyoshi Inako ,  Naoki Nakajima

IPC: H04B1/18

CPC classification number: H04H40/18 ,  H04H20/30 ,  H04H60/43 ,  H04H2201/183

Abstract: A broadcasting receiver suitable for receiving broadcasting signal transmitted with signal format is provided in which carrier wave is allocated in a frequency channel with certain frequency offset and signal intensity, which comprises: an information acquiring means for acquiring information related to the frequency channel in seek; and a station existence determining means for determining whether the frequency channel is station-existent or not based on information acquired by the information acquiring means; and wherein, the information acquiring means acquires information for receiving intensity of carrier wave and information for frequency offset.

Abstract translation: 提供一种适用于接收以信号格式发送的广播信号的广播接收机，其中载波在具有特定频率偏移和信号强度的频道中分配，其包括：信息获取装置，用于获取与寻道中的频道相关的信息; 以及站存在确定装置，用于基于由所述信息获取装置获取的信息来确定所述频道是否存在; 并且其中，所述信息获取装置获取用于接收载波强度的信息和用于频率偏移的信息。

公开(公告)号：US20110275640A1

公开(公告)日：2011-11-10

申请号：US13067110

申请日：2011-05-10

Applicant: Masaki Meguro ,  Tomiichiro Oda ,  Yasuhiro Nakagami ,  Shinji Marumoto ,  Kazuo Koyama ,  Isao Kaneko

Inventor： Masaki Meguro ,  Tomiichiro Oda ,  Yasuhiro Nakagami ,  Shinji Marumoto ,  Kazuo Koyama ,  Isao Kaneko

IPC: A61K31/53 ,  A61K31/50 ,  A61P25/28 ,  A61P3/10 ,  A61P25/02 ,  A61P13/12 ,  A61P25/00 ,  A61P35/00 ,  A61P9/00 ,  A61K31/505 ,  A61P7/00

CPC classification number: C07D239/48 ,  A61K31/50 ,  A61K31/505 ,  A61K31/53 ,  C07D237/20 ,  C07D237/22 ,  C07D239/50 ,  C07D241/20 ,  C07D251/18 ,  C07D251/48 ,  C07D251/52 ,  C07D251/70

Abstract: The present invention relates to preventives or remedies for Alzheimer's disease, or to amyloid protein fibril-formation inhibitors, which include as an active ingredient a compound of general formula (I) below or a pharmacologically permitted salt thereof; and also to nitrogen-containing heteroaryl derivatives having specific substituents, or pharmacologically permitted salts thereof, which are valuable as preventives or remedies for Alzheimer's disease, or as amyloid protein fibril-formation inhibitors: (where, R1 and R2 are H or alkyl; Z1 and Z2 are H, alkyl, alkoxy, haloalkyl or halogeno; Z3 is alkoxy, SH, alkylthio, NH2, mono- or di-alkylamino, OH or halogeno; Z4 and Z5 are H or halogeno; and A is 4,6-pyrimidine-1,3-diyl, 1,3,5-triazine-2,6-diyl, etc).

Abstract translation: 本发明涉及阿尔茨海默病的预防药物或补救剂，或淀粉样蛋白原纤维形成抑制剂，其包括作为活性成分的下列通式（I）的化合物或其药理学允许的盐; 以及具有特定取代基的含氮杂芳基衍生物或其药学上允许的盐，其作为阿尔茨海默氏病的预防剂或治疗剂是有价值的，或作为淀粉样蛋白原纤维形成抑制剂：（其中，R 1和R 2为H或烷基; Z 1 Z 2是H，烷基，烷氧基，卤代烷基或卤代; Z 3是烷氧基，SH，烷硫基，NH 2，一或二烷基氨基，OH或卤素; Z 4和Z 5是H或卤素; A是4,6- -1,3-二基，1,3,5-三嗪-2,6-二基等）。

公开(公告)号：US08003645B2

公开(公告)日：2011-08-23

申请号：US12068407

申请日：2008-02-06

Applicant: Masaki Meguro ,  Tomichiro Oda ,  Yasuhiro Nakagami ,  Shinji Marumoto ,  Kazuo Koyama ,  Isao Kaneko

Inventor： Masaki Meguro ,  Tomichiro Oda ,  Yasuhiro Nakagami ,  Shinji Marumoto ,  Kazuo Koyama ,  Isao Kaneko

IPC: C07D251/00 ,  C07D251/18 ,  C07D251/48

CPC classification number: C07D239/48 ,  A61K31/50 ,  A61K31/505 ,  A61K31/53 ,  C07D237/20 ,  C07D237/22 ,  C07D239/50 ,  C07D241/20 ,  C07D251/18 ,  C07D251/48 ,  C07D251/52 ,  C07D251/70

Abstract: The present invention relates to preventives or remedies for Alzheimer's disease, or to amyloid protein fibril-formation inhibitors, which include as an active ingredient a compound of general formula (I) below or a pharmacologically permitted salt thereof; and also to nitrogen-containing heteroaryl derivatives having specific substituents, or pharmacologically permitted salts thereof, which are valuable as preventives or remedies for Alzheimer's disease, or as amyloid protein fibril-formation inhibitors: (where, R1 and R2 are H or alkyl; Z1 and Z2 are H, alkyl, alkoxy, haloalkyl or halogeno; Z3 is alkoxy, SH, alkylthio, NH2, mono- or di-alkylamino, OH or halogeno; Z4 and Z5 are H or halogeno; and A is 4,6-pyrimidine-1,3-diyl, 1,3,5-triazine-2,6-diyl, etc).

Abstract translation: 本发明涉及阿尔茨海默病的预防药物或补救剂，或淀粉样蛋白原纤维形成抑制剂，其包括作为活性成分的下列通式（I）的化合物或其药理学允许的盐; 以及具有特定取代基的含氮杂芳基衍生物或其药学上允许的盐，其作为阿尔茨海默氏病的预防剂或治疗剂是有价值的，或作为淀粉样蛋白原纤维形成抑制剂：（其中，R 1和R 2为H或烷基; Z 1 Z 2是H，烷基，烷氧基，卤代烷基或卤代; Z 3是烷氧基，SH，烷硫基，NH 2，一或二烷基氨基，OH或卤素; Z 4和Z 5是H或卤素; A是4,6- -1,3-二基，1,3,5-三嗪-2,6-二基等）。

公开(公告)号：US20100227579A1

公开(公告)日：2010-09-09

申请号：US12310596

申请日：2007-08-30

Applicant: Kazuo Koyama ,  Masanori Ishida ,  Kazuyoshi Inako ,  Naoki Nakajima

Inventor： Kazuo Koyama ,  Masanori Ishida ,  Kazuyoshi Inako ,  Naoki Nakajima

IPC: H04B1/18

CPC classification number: H03J1/0091 ,  H04H20/30 ,  H04H20/89 ,  H04H40/18 ,  H04H60/41 ,  H04H2201/183

Abstract: A broadcasting receiver suitable for receiving a broadcasting signal transmitted in an IBOC signal format, comprises: a channel seek directing means for directing to start a channel seeking operation that selects selectable channel in an order of frequency; a channel seek controlling means for starting and controlling the channel seeking operation in accordance with the direction of the channel seek directing means; and a multichannel determining means for determining whether a selected frequency channel is providing multichannel digital broadcasting or not; and wherein the channel seek controlling means selects a next subchannel in an order of identification code before searching for the next frequency channel, if it is determined by the multichannel determining means that the selected frequency channel is providing the multichannel digital broadcasting.

Abstract translation: 适用于接收以IBOC信号格式发送的广播信号的广播接收机包括：信道寻道引导装置，用于引导以频率顺序选择可选频道的频道搜索操作; 频道搜索控制装置，用于根据频道搜索引导装置的方向启动和控制频道搜索​​操作; 以及多通道确定装置，用于确定所选择的频道是否正在提供多声道数字广播; 并且其中，如果由所述多通道确定装置确定所选择的频道正在提供所述多声道数字广播，则所述频道搜索控制装置以搜索下一个频道之前的识别码的顺序选择下一个子信道。

公开(公告)号：US20100210228A1

公开(公告)日：2010-08-19

申请号：US12310614

申请日：2007-08-30

Applicant: Masanori Ishida ,  Kazuo Koyama ,  Kazuyoshi Inako ,  Naoki Nakajima

Inventor： Masanori Ishida ,  Kazuo Koyama ,  Kazuyoshi Inako ,  Naoki Nakajima

IPC: H04B1/18

CPC classification number: H04H40/18 ,  H04H20/30 ,  H04H60/43 ,  H04H2201/183

Abstract: A broadcasting receiver suitable for receiving broadcasting signal transmitted with signal format is provided in which carrier wave is allocated in a frequency channel with certain frequency offset and signal intensity, which comprises: an information acquiring means for acquiring information related to the frequency channel in seek; and a station existence determining means for determining whether the frequency channel is station-existent or not based on information acquired by the information acquiring means; and wherein, the information acquiring means acquires information for receiving intensity of carrier wave and information for frequency offset.

Abstract translation: 提供一种适用于接收以信号格式发送的广播信号的广播接收机，其中载波在具有特定频率偏移和信号强度的频道中分配，其包括：信息获取装置，用于获取与寻道中的频道相关的信息; 以及站存在确定装置，用于基于由所述信息获取装置获取的信息来确定所述频道是否存在; 并且其中，所述信息获取装置获取用于接收载波强度的信息和用于频率偏移的信息。

公开(公告)号：US20090286794A1

公开(公告)日：2009-11-19

申请号：US12458890

申请日：2009-07-27

Applicant: Masaki Meguro ,  Tomiichiro Oda ,  Yasuhiro Nakagami ,  Shinji Marumoto ,  Kazuo Koyama ,  Isao Kaneko

Inventor： Masaki Meguro ,  Tomiichiro Oda ,  Yasuhiro Nakagami ,  Shinji Marumoto ,  Kazuo Koyama ,  Isao Kaneko

IPC: A61K31/53 ,  C07D251/18 ,  C07D241/10 ,  A61K31/4965 ,  C07D239/02 ,  C07D239/42

CPC classification number: C07D239/48 ,  A61K31/50 ,  A61K31/505 ,  A61K31/53 ,  C07D237/20 ,  C07D237/22 ,  C07D239/50 ,  C07D241/20 ,  C07D251/18 ,  C07D251/48 ,  C07D251/52 ,  C07D251/70

Abstract: The present invention relates to preventives or remedies for Alzheimer's disease, or to amyloid protein fibril-formation inhibitors, which include as an active ingredient a compound of general formula (I) below or a pharmacologically permitted salt thereof; and also to nitrogen-containing heteroaryl derivatives having specific substituents, or pharmacologically permitted salts thereof, which are valuable as preventives or remedies for Alzheimer's disease, or as amyloid protein fibril-formation inhibitors: (where, R1 and R2 are H or alkyl; Z1 and Z2 are H, alkyl, alkoxy, haloalkyl or halogeno; Z3 is alkoxy, SH, alkylthio, NH2, mono- or di-alkylamino, OH or halogeno; Z4 and Z5 are H or halogeno; and A is 4,6-pyrimidine-1,3-diyl, 1,3,5-triazine-2,6-diyl, etc).

Abstract translation: 本发明涉及阿尔茨海默病的预防药物或补救剂，或淀粉样蛋白原纤维形成抑制剂，其包括作为活性成分的下列通式（I）的化合物或其药理学允许的盐; 以及具有特定取代基的含氮杂芳基衍生物或其药学上允许的盐，其作为阿尔茨海默氏病的预防剂或治疗剂是有价值的，或作为淀粉样蛋白原纤维形成抑制剂：（其中，R 1和R 2为H或烷基; Z 1 Z 2是H，烷基，烷氧基，卤代烷基或卤代; Z 3是烷氧基，SH，烷硫基，NH 2，一或二烷基氨基，OH或卤素; Z 4和Z 5是H或卤素; A是4,6- -1,3-二基，1,3,5-三嗪-2,6-二基等）。

公开(公告)号：US07504393B2

公开(公告)日：2009-03-17

申请号：US11583404

申请日：2006-10-19

Applicant: Kazuo Koyama ,  Shinji Marumoto ,  Narihiro Toda ,  Hiroshi Kogen ,  Keiko Suzuki

Inventor： Kazuo Koyama ,  Shinji Marumoto ,  Narihiro Toda ,  Hiroshi Kogen ,  Keiko Suzuki

IPC: A61K31/55 ,  A61K31/4704 ,  C07D215/06 ,  C07D223/04

CPC classification number: C07C219/30 ,  C07C271/44 ,  C07C323/20 ,  C07C323/25 ,  C07C333/04 ,  C07D213/64 ,  C07D213/68 ,  C07D215/20 ,  C07D317/58 ,  C07D333/38

Abstract: A compound of the formula (I): wherein R1 is a C1-C6 alkyl group, an amino group, a (C1-C6 alkyl)amino group, a di(C1-C6 alkyl)amino group or a nitrogen-containing saturated heterocyclic group; R3 is a hydrogen atom or a C1-C6 alkyl group; Arom is an unsubstituted or substituted aryl group or an unsubstituted or substituted heteroaryl group; wherein the substituted aryl group is substituted at 1 to 5 positions and the substituted heteroaryl group is substituted at 1 to 3 positions; and wherein the substituents of the aryl group and of the heteroaryl group are independently selected from the group consisting of halogen atom, C1-C6 alkyl, halogeno C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C3 alkylenedioxy, C1-C7 alkanoyl, C2-C7 alkyloxycarbonyl, amino, C1-C7 alkanoylamino, hydroxyl, mercapto, cyano, nitro and carboxyl; A is a C1-C6 alkylene group; Ra together with R2 is a C2-C3 alkylene group containing a double bond; E is a single bond, an oxygen atom, a sulfur atom or a group of the formula: —NR4—, wherein R4 is a hydrogen atom or a C1-C7 alkanoyl group; X1 and X2 are the same or different and are an oxygen atom or a sulfur atom, or a pharmacologically acceptable salt or ester thereof.

Abstract translation: 式（I）的化合物：其中R1是C1-C6烷基，氨基，（C1-C6烷基）氨基，二（C1-C6烷基）氨基或含氮饱和杂环 组; R3是氢原子或C1-C6烷基; Arom是未取代或取代的芳基或未取代或取代的杂芳基; 其中取代的芳基在1至5个位置被取代，取代的杂芳基在1至3个位置被取代; 并且其中芳基和杂芳基的取代基独立地选自卤素原子，C 1 -C 6烷基，卤代C 1 -C 6烷基，C 1 -C 6烷氧基，C 1 -C 6烷硫基，C 1 -C 3亚烷基二氧基， C 1 -C 7烷酰基，C 2 -C 7烷氧基羰基，氨基，C 1 -C 7烷酰氨基，羟基，巯基，氰基，硝基和羧基; A是C1-C6亚烷基; R a与R 2一起是含有双键的C 2 -C 3亚烷基; E是单键，氧原子，硫原子或式-NR4-基团，其中R4是氢原子或C1-C7烷酰基; X1和X2相同或不同，为氧原子或硫原子，或其药理学上可接受的盐或酯。